| Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
Variable | No. of patients | HR | 95% CI | P value | HR | 95% CI | P value | |
Age (years) | ≥70 | 15 | 1.470 | (0.607–3.560) | 0.393 |  |  |  |
<70 | 24 | |||||||
Gender | Male | 32 | 0.409 | (0.156–1.075) | 0.070 | 0.281 | (0.093–0.846) | 0.024 |
Female | 7 | |||||||
ECOG performance status | ≥1 | 2 | 0.894 | (0.119–6.698) | 0.913 |  |  |  |
0 | 37 | |||||||
Borrmann macroscopic type | Non-type 4 | 38 | 0.452 | (0.059–3.439) | 0.443 |  |  |  |
Type 4 | 1 | |||||||
Differentiation | Diffuse | 18 | 0.758 | (0.310–1.854) | 0.543 |  |  |  |
Intestinal | 21 | |||||||
PAN metastasis | (+) | 16 | 1.869 | (0.539–4.854) | 0.201 |  |  |  |
(−) | 23 | |||||||
Hepatic metastasis | (+) | 9 | 2.508 | (0.993–6.333) | 0.052 | 1.718 | (0.530–5.570) | 0.367 |
(−) | 30 | |||||||
RECIST | SD, PD | 10 | 1.769 | (0.705–4.439) | 0.225 |  |  |  |
CR, PR | 29 | |||||||
Histological evaluation | 0, 1a, 1b | 17 | 2.84 | (1.152–7.000) | 0.023 | 1.938 | (0.612–6.129) | 0.260 |
2, 3 | 22 | |||||||
CD42b expression | ≥10% | 24 | 3.644 | (1.213–10.95) | 0.021 | 4.406 | (1.325–14.65) | 0.016 |
<10% | 15 | |||||||
Podoplanin expression | (+) | 28 | 1.411 | (0.512–3.889) | 0.505 |  |  |  |
(−) | 11 | |||||||
SNAIL expression | (+) | 30 | 1.736 | (0.664–4.539) | 0.261 |  |  |  |
(−) | 9 | |||||||
FOXP3 expression | (+) | 7 | 1.272 | (0.369–4.386) | 0.703 |  |  |  |
(−) | 32 |